Andere Sprachen Syncona Limited

Aktien

Markt geschlossen - London S.E. Andere Börsenplätze 17:35:14 26.04.2024			% 5 Tage	% 1. Jan.
128,4 ^GBX	+1,10 %		+5,77 %	+4,05 %

11.04.	Syncona verkauft Beteiligung an Beteiligungsunternehmen für 7,4 Millionen GBP	AN
11.04.	Syncona verkauft Beteiligung an Portfoliounternehmen an Century Therapeutics	MT

Syncona agrees to sell stake in investee company for GBP7.4 million	11.04.
Syncona to Sell Stake in Portfolio Company to Century Therapeutics	11.04.
Syncona : Ascend acquires GMP manufacturing capacity in Alachua, Florida; Enters long-term partnership with Beacon Therapeutics for clinical and commercial AAV production	09.04.
BEST OF THE BROKERS	08.04.
Syncona notes investee Achilles's annual loss narrows	04.04.
Syncona : Autolus Therapeutics announces acceptance of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA)	02.04.
Syncona : Autolus Therapeutics Announces Changes to its Board of Directors (1)	02.04.
Syncona portfolio company Autolus posts widened loss for 2023	14.03.
Syncona’s Takeover of Freeline Therapeutics Becomes Effective	20.02.
Freeline shareholders approve Syncona acquisition	12.02.
Freeline Therapeutics' Shareholders Approve Acquisition by Syncona	12.02.
Syncona portfolio strengthens in third quarter thanks to Autolus	08.02.
Syncona's Fiscal Q3 NAV Declines	08.02.
Tranche Update on Syncona Limited's Equity Buyback Plan announced on September 29, 2023.	08.02.
Syncona notes FDA acceptance of Autolus's BLA for obe-cel	22.01.
Syncona says Freeline trial for Gaucher disease treatment positive	19.01.
Syncona : Anaveon announces publication of ANV419 Phase I data in The Journal for ImmunoTherapy of Cancer	14.12.
Farma en gezondheid: consolidatie gaat door	12.12.
Farmaceutica e salute: continua il consolidamento	11.12.
Farmacia y salud: La consolidación continúa	11.12.

Keine Ergebnisse zu dieser Suche